Literature DB >> 33103270

Immune privilege of skin stem cells: What do we know and what can we learn?

Judith Agudo1,2.   

Abstract

The skin forms a barrier that prevents dehydration and keeps us safe from pathogens. To ensure proper function, the skin possesses a myriad of stem cell populations that are essential for maintenance and repair upon damage. In order to protect, the skin is also an active immunological site, with abundant resident immune cells and strong recruitment of even more immune cells during wounding or infection. Such active and strong immunity makes the skin susceptible to a diverse spectrum of autoimmune diseases, such as vitiligo and alopecia areata. Conversely, despite constant immune surveillance, the skin is also a tissue where frequent malignancies occur, which suggests that immune evasion must also take place. Skin stem cells play a crucial role during both regeneration and tumorigenesis. How immune cells, and in particular T cells, interact with skin stem cells and the implications this crosstalk has in skin disease (both autoimmunity and cancer) is not fully understood. Uncovering the mechanisms governing immune-stem cells interactions in the skin is critical for the development of new therapeutic strategies to safeguard susceptible cells during autoimmunity and, conversely, to improve cancer immunotherapy. Here, I will discuss how distinct skin stem cell populations are attacked by, or conversely, cloaked from immune cells, and the implications their differences have in autoimmunity and cancer.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  T cells; autoimmunity; regeneration; squamous cell carcinoma; stem cells

Mesh:

Year:  2020        PMID: 33103270     DOI: 10.1111/exd.14221

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  2 in total

1.  Role of hair follicles in the pathogenesis of arsenical-induced cutaneous damage.

Authors:  Ritesh K Srivastava; Yong Wang; Jasim Khan; Suhail Muzaffar; Madison B Lee; Zhiping Weng; Claire Croutch; Anupam Agarwal; Jessy Deshane; Mohammad Athar
Journal:  Ann N Y Acad Sci       Date:  2022-06-09       Impact factor: 6.499

2.  Case Report: Significant Efficacy of Pyrotinib in the Treatment of Extensive Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Cutaneous Metastases: A Report of Five Cases.

Authors:  Nan Wang; Lin Li; Youyi Xiong; Jiangrui Chi; Xinwei Liu; Chaochao Zhong; Fang Wang; Yuanting Gu
Journal:  Front Oncol       Date:  2021-12-16       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.